Profile
SYBX VRTX REGN VRNA ARGX ALNY
Company Name Synlogic, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $7.25M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Mary Beth Dooley Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
SYBX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
SYBX VRTX REGN VRNA ARGX ALNY
Last Close $1.69 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $1.83 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.97 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -7.65 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 74.23 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
SYBX VRTX REGN VRNA ARGX ALNY
1 Month Return -7.65 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 18.18 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 56.48 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 23.36 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 20.71 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 24.26 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SYBX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
SYBX VRTX REGN VRNA ARGX ALNY
Asset Growth -73.76 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -99.76 % 1.16 % - 26.81 %
Revenue Growth -99.76 % 0.99 % - 22.97 %
Revenue 3 Year -99.86 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year -99.94 % 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 59.22 % 9.09 % -131.37 % 24.59 %
Net Income Growth 59.22 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 88.33 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 92.47 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 86.3 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 25.76 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 38.66 % - -143.33 % -107.98 %
Operating 3 Year CFG 81.66 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 93.06 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 78.95 % -100 % 40.15 % 97.08 %
EPS Growth 78.21 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 78.21 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -84.06 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -97.38 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -98.65 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 102.47 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -100 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 38.89 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
SYBX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -19.49 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -26.47 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -41.12 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 76 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.33 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.33 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 126.56 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.81 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -1.91 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -1.91 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
SYBX VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 100% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.02B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.02B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -1.92 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
SYBX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.01B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.01B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.02B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
SYBX VRTX REGN VRNA ARGX ALNY
Net Income $-0.02B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.03B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.51
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ETFs With Exposure to SYBX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00001 336.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
VXF Vanguard Extended Market Index Fund 0.00006 216.28
IWC iShares Micro-Cap ETF 0.00835 166.03
VUN.TO Vanguard U.S. Total Market Index ETF 0.00001 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00001 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.38
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.36
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.22
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.21
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.21
VGRO.TO Vanguard Growth ETF Portfolio 0 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
DFAU Dimensional US Core Equity Market ETF 0 47.29
DFAT Dimensional U.S. Targeted Value ETF 0.000155 66.28
VTSAX Vanguard Total Stock Market Index Fund 0.00001 163.89
INNO Harbor Disruptive Innovation ETF 0 17.72
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00006 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00001 163.92
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000630922 16.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00006 164.02
DFQTX DFA U.S. Core Equity 2 Portfolio 0 45.68
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 475.91
VEMPX Vanguard Extended Market Index InstlPlus 0.00006 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 307.49
Unlock